Comparative characterization of OncoProâ„¢ and Wnt-based media reveals distinct phenotypic and pharmacologic states in patient-derived tumor organoids
Bron
Experimental hematology & oncology - ISSN 2162-3619-15:1 (2026) p.
Assessing clinical value of new treatment strategies : ESMO-MCBS and ASCO-VF evaluation in phase III trials at ASCO Annual Meeting 2022
Bron
JCO oncology practice - ISSN 2688-1527-21:9 (2025) p. 1-11
91³Ô¹ÏÍøs and prospects of LAG-3 inhibition in advanced gastric and gastroesophageal junction cancer : insights from the RELATIVITY-060 trial
Bron
Journal of Gastrointestinal Oncology - ISSN 2078-6891-15:6 (2024) p. 2735-2738
Development and validation of the Normalized Organoid Growth Rate (NOGR) metric in brightfield imaging-based assays
Bron
Communications Biology - ISSN 2399-3642-7:1 (2024) p. 1-11
Advancements in research and treatment applications of patient-derived tumor organoids in colorectal cancer
Bron
Cancers - ISSN 2072-6694-16:15 (2024) p. 1-20